Alan Colowick

Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy

John A. Glaspy, J. Jadeja, Glen R. Justice et al. · British Journal of Cancer · 2002 · 171 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study

Dusan Kotasek, G. Steger, Wylam Faught et al. · European Journal of Cancer · 2003 · 140 citations

Medicine, Oncology, Pharmacology +6

Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper

Alan Colowick, Rhonda L. Bohn, Jerry Avorn et al. · Blood · 2000 · 94 citations

Life Sciences, Hematology, Immunology +14

A randomized, active‐control, pilot trial of front‐loaded dosing regimens of darbepoetin‐alfa for the treatment of patients with anemia during chemotherapy for malignant disease

John A. Glaspy, J Jadeja, Glen R. Justice et al. · Cancer · 2003 · 89 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer

Robert E. Smith, Ishmael Jaiyesimi, Luís Meza et al. · British Journal of Cancer · 2001 · 87 citations · Full text

Medicine, Hematology, Pharmacology +13